Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

5.170 +0.110 (+2.17%)
Streaming Delayed Price Updated: 10:02 AM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Nvidia Invested $50 million into This AI Drug Discovery Biotech
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from 
Via MarketBeat
Topics Artificial Intelligence
3 Biotech Stocks Using AI to Change Healthcare Forever
These three biotech firms are leveraging artificial intelligence to revolutionize therapeutics and make disease a thing of the past. 
Via InvestorPlace
Benzinga's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About
Investors are on the hunt for undervalued, under followed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. 
Via Benzinga
Why Recursion Pharmaceuticals Stock Is Skyrocketing This Week (Hint: Thanks, Nvidia)
The small biotech is enjoying the rewards of being linked to one of the hottest AI giants around. 
Via The Motley Fool
Where Recursion Pharmaceuticals Stands With Analysts
Via Benzinga
Why Shares of Recursion Pharmaceuticals Are Skyrocketing Wednesday
The company just received a $50 million investment from Nvidia. 
Via The Motley Fool
Did Nvidia Make Recursion Pharmaceuticals (RXRX) Stock the Next AI Play?
RXRX stock is the talk of Wall Street today after Recursion Pharmaceuticals shot up 100% on a new Nvidia investment. 
Via InvestorPlace
Why Recursion Pharmaceuticals (RXRX) Stock Is Falling Thursday
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) shares are trading lower on Thursday as traders appear to be taking profits. The stock rallied on Wednesday after the company announced a $50 m 
Via Benzinga
Top Trending Stocks: Recursion Pharmaceuticals, Beyond Meat, Tesla, Disney, NIO in Focus
Via Benzinga
Nvidia Just Invested in This Pharmaceutical Company, Causing Its Stock Price to Skyrocket
Nvidia's investment in Recursion caused its stock price to jump dramatically on Tuesday. 
Via The Motley Fool
RXRX Stock: Nvidia Investment Sends Recursion Pharmaceuticals Soaring
Nvidia just invested millions into Recursion Pharmaceuticals, bolstering AI integration in biotech but also presenting risks for RXRX stock. 
Via InvestorPlace
Gold Rises Over 1%; Recursion Pharmaceuticals Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Wednesday. The Dow traded up 0.33% to 34,374.56 while the NASDAQ rose 1.21% to 13,926.89. The S&P 500,... 
Via Benzinga
Recursion Pharmaceuticals (NASDAQ: RXRX) Forms Powerful Partnership with NVIDIA (NASDAQ: NVDA)
A $50 Million Investment to Boost AI Capabilities in Drug Discovery Recursion Pharmaceuticals (NASDAQ: RXRX), a trailblazer in TechBio that 
Via Spotlight Growth
Topics Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Stocks Extend Rally On Cooler-Than-Expected CPI Reading
The S&P 500 Index and Nasdaq Composite sport solid midday leads, as investors hope the data may push the Federal Reserve away from more interest rate hikes. 
Via Talk Markets
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
Via Benzinga
Why Recursion Pharmaceuticals Stock is Skyrocketing Today?
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares are trading higher after the company announced a $50 million investment by NVIDIA Corporation (NASDAQ: NVDA), executed as a private  
Via Benzinga
S&P 500 Gains 1%; US Crude Oil Inventories Increase More Than Projected
U.S. stocks traded higher midway through trading, with the S&P 500 gaining 1% on Wednesday. The Dow traded up 0.84% to 34,550.13 while the NASDAQ rose 1.32% to 13,941.87. The S&P 500, also rose,... 
Via Benzinga
Recursion Catapults 70% On Nvidia Investment For AI In Drug Development
Nvidia is hoping to help this company accelerate its efforts in AI-related drug development. 
Via Investor's Business Daily
InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Nasdaq Rises Over 1%; US Inflation Rate Falls In June
U.S. stocks traded higher this morning, with the Nasdaq Composite surging over 1% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.78% to 34,527.32 while the NASDAQ rose 1.18%... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments faster 
From Recursion Pharmaceuticals
Via GlobeNewswire
Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom
AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider. 
Via InvestorPlace
Cash In on the Longevity Boom: 3 Biotech Stocks to Buy Now
With longevity back in the news, many investors are wondering which biotech stocks to buy to best cash in on the growing trend. 
Via InvestorPlace
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled
Recursion's small molecule is the first therapeutic candidate to be advanced to an industry-sponsored Phase 2 clinical trial for cerebral cavernous malformation (CCM). CCM is a devastating... 
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion Pharmaceuticals Is Going Big on AI. Here's Why It Could Be Worth Buying
It's competing in a soon-to-be hotly contested space. 
Via The Motley Fool
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.